News | March 02, 2024
Cipla incorporates JV company in USA
Cipla completes transfer of Generics Business Undertaking
Cipla completes transfer of Generics Business Undertaking
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Eugia Pharma Specialities restarts production at terminally sterilized product lines
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The plant will drive pharmaceutical innovation in the Northeastern India
BHL will undertake the development and supply of these molecules
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
The facility will accommodate over 1,500 employees
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Subscribe To Our Newsletter & Stay Updated
